Matches in Wikidata for { <http://www.wikidata.org/entity/Q63319547> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q63319547 description "clinical trial" @default.
- Q63319547 description "ensayu clínicu" @default.
- Q63319547 description "klinisch onderzoek" @default.
- Q63319547 description "клінічне випробування" @default.
- Q63319547 name "Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease" @default.
- Q63319547 type Item @default.
- Q63319547 label "Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease" @default.
- Q63319547 prefLabel "Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease" @default.
- Q63319547 P1050 Q63319547-50A0290F-0AAC-4FB2-98B4-2433D20A8A75 @default.
- Q63319547 P1050 Q63319547-61AF478C-A362-4EB7-B220-42F5F28C0428 @default.
- Q63319547 P1050 Q63319547-798A3166-0D0F-4CEF-93D3-30BA89E220AF @default.
- Q63319547 P1050 Q63319547-A2F60657-8C1B-4713-B499-C1554FFEDD10 @default.
- Q63319547 P1050 Q63319547-CD61F3D7-14C9-4474-BD4C-82D4F0F9029D @default.
- Q63319547 P1132 Q63319547-8925A87C-B97A-49D0-8EFC-D2F3EF35634B @default.
- Q63319547 P1476 Q63319547-069AE607-B6C4-4888-8DF9-81FF771CA676 @default.
- Q63319547 P17 Q63319547-216F0B09-3A5C-460C-85E0-2F594BC9E807 @default.
- Q63319547 P3098 Q63319547-EC575EB7-E348-4B73-9804-8D004E648639 @default.
- Q63319547 P31 Q63319547-A444F461-469B-4A96-876F-E71CDAE915A9 @default.
- Q63319547 P4844 Q63319547-6A818133-615D-4A10-953B-6570F941FAE3 @default.
- Q63319547 P4844 Q63319547-85673825-35B4-42D0-A9D1-95375ACD3C2B @default.
- Q63319547 P4844 Q63319547-8664AD05-F183-432C-BC72-939C2B705167 @default.
- Q63319547 P4844 Q63319547-8D249E79-0310-49BD-A30C-7DA83F1661C6 @default.
- Q63319547 P4844 Q63319547-DB7534F8-51FE-4AF2-B4FB-46A7CC22E5E7 @default.
- Q63319547 P4844 Q63319547-E49C69B6-A733-44FD-8897-078741AF1D70 @default.
- Q63319547 P580 Q63319547-2F7C2EC3-CD25-4E49-AE0F-A12C6297EADD @default.
- Q63319547 P582 Q63319547-8C78D656-A825-4472-B242-B48A8ED6E22B @default.
- Q63319547 P6099 Q63319547-1F8E2137-8D1B-4B05-ABD5-B48B0895F77A @default.
- Q63319547 P8363 Q63319547-6B810C2D-A633-467A-9893-EC933F51EDA6 @default.
- Q63319547 P859 Q63319547-BE23EB54-A688-495B-8AFB-EE5261C7D335 @default.
- Q63319547 P921 Q63319547-75A6972C-BB4D-45E6-963C-49B54A78165D @default.
- Q63319547 P921 Q63319547-F3B2477D-353B-48EF-81D0-13A0737E0302 @default.
- Q63319547 P1050 Q1349259 @default.
- Q63319547 P1050 Q1418735 @default.
- Q63319547 P1050 Q1878759 @default.
- Q63319547 P1050 Q223911 @default.
- Q63319547 P1050 Q33525 @default.
- Q63319547 P1132 "+216" @default.
- Q63319547 P1476 "A Phase I Trial of Bevacizumab, Temsirolimus Alone and in Combination With Valproic Acid, or Cetuximab in Patients With Advanced Malignancy and Other Indications" @default.
- Q63319547 P17 Q30 @default.
- Q63319547 P3098 "NCT01552434" @default.
- Q63319547 P31 Q30612 @default.
- Q63319547 P4844 Q20801760 @default.
- Q63319547 P4844 Q240642 @default.
- Q63319547 P4844 Q32089 @default.
- Q63319547 P4844 Q413299 @default.
- Q63319547 P4844 Q420296 @default.
- Q63319547 P4844 Q421052 @default.
- Q63319547 P580 "2012-03-16T00:00:00Z" @default.
- Q63319547 P582 "2020-03-31T00:00:00Z" @default.
- Q63319547 P6099 Q5452194 @default.
- Q63319547 P8363 Q78089383 @default.
- Q63319547 P859 Q1525831 @default.
- Q63319547 P921 Q12078 @default.
- Q63319547 P921 Q413299 @default.